Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone in Impaired Glucose Tolerance
NCT00733174Phase 4Unknown
- Sponsor
- Denver Research Institute
- Start
- Mar 2004
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rosiglitazone in impaired glucose tolerance (IGT), sponsored by Denver Research Institute. Status: unknown.
02
Drugs
rosiglitazone
03
Conditions
impaired glucose tolerance (IGT)
Beyond the preview
Go deeper on NCT00733174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00733174.